Stuart J. Perper

520 total citations
16 papers, 410 citations indexed

About

Stuart J. Perper is a scholar working on Immunology, Rheumatology and Oncology. According to data from OpenAlex, Stuart J. Perper has authored 16 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Rheumatology and 5 papers in Oncology. Recurrent topics in Stuart J. Perper's work include Systemic Lupus Erythematosus Research (6 papers), T-cell and B-cell Immunology (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Stuart J. Perper is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), T-cell and B-cell Immunology (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Stuart J. Perper collaborates with scholars based in United States, Australia and Canada. Stuart J. Perper's co-authors include Keith Giza, Cheryl Nickerson‐Nutter, Henry Hess, Daniel M. Scott, Eric T. Whalley, Mark Cornebise, David M. Findlay, Jennifer L. Gommerman, Linda C. Burkly and Lihe Su and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Stuart J. Perper

14 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart J. Perper United States 9 239 129 103 74 70 16 410
Beate Böhm Germany 14 236 1.0× 139 1.1× 101 1.0× 174 2.4× 119 1.7× 23 519
K Williamson United Kingdom 8 211 0.9× 148 1.1× 38 0.4× 132 1.8× 65 0.9× 17 397
Karina Petat‐Dutter Germany 5 182 0.8× 199 1.5× 128 1.2× 85 1.1× 130 1.9× 9 449
Katerina Gkirtzimanaki Greece 9 195 0.8× 242 1.9× 71 0.7× 55 0.7× 96 1.4× 11 481
Li-Na Zhou China 8 165 0.7× 196 1.5× 61 0.6× 19 0.3× 82 1.2× 9 435
Renata Ferri Italy 10 95 0.4× 127 1.0× 60 0.6× 69 0.9× 148 2.1× 11 381
Jian‐Guo Geng United States 8 109 0.5× 200 1.6× 68 0.7× 13 0.2× 91 1.3× 16 420
Elizabeth M. Chislock United States 6 75 0.3× 248 1.9× 39 0.4× 31 0.4× 197 2.8× 6 469

Countries citing papers authored by Stuart J. Perper

Since Specialization
Citations

This map shows the geographic impact of Stuart J. Perper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Perper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Perper more than expected).

Fields of papers citing papers by Stuart J. Perper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart J. Perper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Perper. The network helps show where Stuart J. Perper may publish in the future.

Co-authorship network of co-authors of Stuart J. Perper

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart J. Perper. A scholar is included among the top collaborators of Stuart J. Perper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart J. Perper. Stuart J. Perper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Yuzhen, Lucy Phillips, Christine M. Nelson, et al.. (2025). Quantitative Assessment of Pulmonary Fibrosis in a Murine Model via a Multimodal Imaging Workflow. Chemical & Biomedical Imaging. 3(2). 85–94.
2.
Perper, Stuart J., Susan V. Westmoreland, Swetha Srinivasan, et al.. (2024). Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human Disease. ACR Open Rheumatology. 6(12). 900–911.
3.
Perper, Stuart J., Susan V. Westmoreland, József Kármán, et al.. (2019). Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus. The Journal of Immunology. 203(1). 58–75. 30 indexed citations
4.
Perper, Stuart J., Susan V. Westmoreland, Manuel Duval, et al.. (2017). THU0222 Prophylactic and therapeutic administration of an ANTI-CD40 antagonist antibody blocks and reverses proteinuria and nephritis in NZB/W-F1 mice. Annals of the Rheumatic Diseases. 76. 288–288. 1 indexed citations
5.
Ko, Kichul, Jianing Wang, Stuart J. Perper, et al.. (2016). Bcl‐2 as a Therapeutic Target in Human Tubulointerstitial Inflammation. Arthritis & Rheumatology. 68(11). 2740–2751. 20 indexed citations
6.
Grebe, Kristie M., Stuart J. Perper, Annette Schwartz, et al.. (2015). Venetoclax (ABT-199), a potent and selective BCL-2 inhibitor, is efficacious in NZB/WF1 mouse model of lupus nephritis and reduces human lymphocyte lifespan in vitro (BA4P.127). The Journal of Immunology. 194(1_Supplement). 47.7–47.7. 2 indexed citations
7.
Perper, Stuart J., Andrea Wershof Schwartz, Douglas J. Hartman, et al.. (2015). THU0382 Venetoclax (ABT-199), A Potent and Selective BCL-2 Inhibitor, Prevents Nephritis in Lupus Prone NZB/W F1 Mice by Depleting Selective Lymphocyte Populations While Sparing Platelets. Annals of the Rheumatic Diseases. 74. 334–334. 3 indexed citations
8.
Perper, Stuart J., Edit Tarcsa, Philip D. Bardwell, et al.. (2013). OP0085 Therapeutic Inhibition of Anti-Apoptotic BCL-2 Family Proteins in a Murine Model of Lupus Nephritis. Annals of the Rheumatic Diseases. 72. A79–A79. 1 indexed citations
9.
Mertsching, Elisabeth, Lisa M. Bafetti, Henry Hess, et al.. (2007). A mouse Fcγ-Fcε protein that inhibits mast cells through activation of FcγRIIB, SH2 domain–containing inositol phosphatase 1, and SH2 domain–containing protein tyrosine phosphatases. Journal of Allergy and Clinical Immunology. 121(2). 441–447.e5. 31 indexed citations
10.
Perper, Stuart J., Beth Browning, Linda C. Burkly, et al.. (2006). TWEAK Is a Novel Arthritogenic Mediator. The Journal of Immunology. 177(4). 2610–2620. 132 indexed citations
11.
Pepinsky, R. Blake, Mark Cornebise, Alan Gill, et al.. (2005). Design, Synthesis, and Analysis of a Polyethelene Glycol-Modified (PEGylated) Small Molecule Inhibitor of Integrin α4β1 with Improved Pharmaceutical Properties. Journal of Pharmacology and Experimental Therapeutics. 312(2). 742–750. 17 indexed citations
12.
Gommerman, Jennifer L., Keith Giza, Stuart J. Perper, et al.. (2003). A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. Journal of Clinical Investigation. 112(5). 755–767. 51 indexed citations
13.
Leone, Diane R., Keith Giza, Alan Gill, et al.. (2003). An Assessment of the Mechanistic Differences Between Two Integrin α4β1 Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune Encephalomyelitis. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1150–1162. 48 indexed citations
14.
Gommerman, Jennifer L., Keith Giza, Stuart J. Perper, et al.. (2003). A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. Journal of Clinical Investigation. 112(5). 755–767. 4 indexed citations
15.
Vanderlugt, Carol L., Cheryl Nickerson‐Nutter, Mark Cornebise, et al.. (2003). Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE. Blood. 102(13). 4464–4471. 47 indexed citations
16.
Bacha, Patricia, et al.. (1992). Anti‐arthritic effects demonstrated by an interleukin‐2 receptor‐targeted cytotoxin (DAB486IL‐2) in rat adjuvant arthritis. European Journal of Immunology. 22(7). 1673–1679. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beate Böhm Breakdown of academic impact, for papers by K Williamson Breakdown of academic impact, for papers by Karina Petat‐Dutter Breakdown of academic impact, for papers by Katerina Gkirtzimanaki Breakdown of academic impact, for papers by Li-Na Zhou Breakdown of academic impact, for papers by Renata Ferri Breakdown of academic impact, for papers by Jian‐Guo Geng Breakdown of academic impact, for papers by Elizabeth M. Chislock
Rankless by CCL
2026